Enesi Pharma and BARDA Drive Enter Public-Private Partnership to Develop ImplaVax® Solid Dose Vaccine Delivery Technology Against Influenza

By In The News
April 15, 2019 in The Headlines

Recommended Posts

In The News

Posted April 15, 2019

- Share

Posted April 15, 2019

OXFORD, England, April 15, 2019 /PRNewswire/ -- Enesi Pharma ("Enesi"), an innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products, announces it has entered a public-private partnership with the U.S. Biomedical Advanced Research and...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  222618
2. Jaydee
  18144
3. deicer
  13666
4. Kip Powick
  12356
5. dagger
  9615
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  273.1k
- Total Posts
  
  566.7k

Sign In

Enesi Pharma and BARDA Drive Enter Public-Private Partnership to Develop ImplaVax® Solid Dose Vaccine Delivery Technology Against Influenza

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support